Documents | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Documents

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Document Type

  • Publication (21)
  • DEA Administrator Remarks (4)
  • Speech (2)
  • Testimony (2)

Publication Type

  • Intelligence (11)
  • DEA Administrator (6)
  • Drug Prevention (5)
  • Forensics (2)

Drug Name

  • Fentanyl (11)
  • Methamphetamine (10)
  • Drugs of Concern (7)
  • Cannabis (5)
  • Xylazine (5)
  • Marijuana (4)
  • Cocaine (2)
  • Synthetic Opioids (2)
  • Designer Drugs (1)
  • Hallucinogen (1)
  • Ketamine (1)
  • Spice/K2, Synthetic Marijuana (1)
  • Steroids (1)
  • Narcóticos (opioides) (23)
  • Heroin (7)

Topic

  • Forensic Sciences (2)
  • Family (1)
  • Self Help/Personal Growth (1)
Clear All Results
DOCUMENT

CY 2023 Annual Heroin Report

Septiembre 22, 2025
Publication
The United States Drug Enforcement Administration (DEA) Office of Forensic Sciences laboratory system is comprised of eight regional laboratories distributed across the United States. Heroin seizures ranging in weight from residue to multiple kilograms are routinely analyzed in these laboratories. The analytical protocol typically requires the identification of heroin, other...
Septiembre 22, 2025
DOCUMENT

CY 2024 Heroin Report

Septiembre 22, 2025
Publication
The United States Drug Enforcement Administration (DEA) Office of Forensic Sciences laboratory system is comprised of eight regional laboratories distributed across the United States. Heroin seizures ranging in weight from residue to multiple kilograms are routinely analyzed in these laboratories. The analytical protocol typically requires the identification of heroin, other...
Septiembre 22, 2025
DOCUMENT

DEA Applauds the Repeal of the X-Waiver

Enero 17, 2023
DEA Administrator Remarks
“In this moment, when the United States is suffering tens of thousands of opioid-related drug poisoning deaths every year, the DEA’s top priority is doing everything in our power to save lives,” said Administrator Milgram. “Medication for opioid use disorder helps those who are fighting to overcome substance use disorder...
Enero 17, 2023
DOCUMENT

CY 2021 Fentanyl Profiling Program (FPP)

Agosto 22, 2022
Publication
The DEA’s Fentanyl Profiling Program (FPP) performs in-depth chemical analyses on fentanyl and fentanyl-related samples obtained from seizures throughout the United States. This report summarizes the findings for these analyses for Calendar Year 2021. FPP data is not intended to reflect U.S. market share, but is rather a snapshot of...
Agosto 22, 2022
DOCUMENT

DEA Administrator's Statement on Potential Mass Fentanyl Poisoning Event in Gadsden County, Florida

Julio 02, 2022
DEA Administrator Remarks
DEA Administrator Anne Milgram's statement on a potential mass fentanyl poisoning event in Gadsden County, Florida on July 2, 2022.
Julio 02, 2022
DOCUMENT

Respuesta al Aumento Nacional de Sobredosis Masivas Relacionadas con el Fentanilo

Abril 06, 2022
Publication
La DEA está observando un repunte en todo el país de sucesos de sobredosis masivas relacionados con el fentanilo que implican tres o más sobredosis que ocurren cerca en el tiempo en el mismo lugar. Solo en los dos últimos meses, al menos 7 eventos confirmados de sobredosis masiva en...
Abril 06, 2022
DOCUMENT

Responding to Nationwide Increases in Fentanyl-Related Mass-Overdose Events

Abril 06, 2022
Publication
The DEA is seeing a nationwide spike in fentanyl-related mass-overdose events involving three or more overdoses occurring close in time at the same location. In just the past two months, there have been at least 7 confirmed mass overdose events across the United States resulting in 58 overdoses and 29...
Abril 06, 2022
DOCUMENT

Administrator Anne Milgram Remarks on ONDCP Press Call Addressing the Overdose Epidemic

Noviembre 17, 2021
DEA Administrator Remarks
DEA’s mission is to keep American communities safe and healthy and we are in the midst of an overdose crisis that has reached a devastating new height. 265 people die every day from drug overdoses. Countless more [people] overdose and are fortunate to survive. This is a national crisis. It...
Noviembre 17, 2021
DOCUMENT

Illicit Opioid Availability in Pennsylvania 2020

Diciembre 30, 2020
Publication
The increasing availability of illicit opioids is the most significant drug threat in Pennsylvania. The Philadelphia Field Division (PFD) monitors this threat closely, periodically reviewing multiple data indicators, in conjunction with investigative information, to continually assess the threat, then share analytical findings with stakeholders in federal, state, and municipal governments.
Diciembre 30, 2020
DOCUMENT

Remarks by DEA Acting Assistant Administrator Timothy McDermott at the National Healthcare Fraud Takedown Press Conference

Septiembre 30, 2020
DEA Administrator Remarks
Due to the efforts of DEA and our partners, from January 2017 through August 2020, we have seen the number of opioid prescriptions drop nearly 37 percent, a reduction in over 47 percent of opioids dispensed, and most importantly -- an 18 percent drop in prescription overdose deaths over the...
Septiembre 30, 2020
Showing 1 - 10 of 29 results

Paginación

  • Current page 1
  • Página 2
  • Página 3
  • Siguiente página ›
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster